Amplia Therapeutics Limited (ASX:ATX)

Amplia Therapeutics Revenue

In the fiscal year ending March 31, 2026, Amplia Therapeutics had annual revenue of 4.79M AUD with 26.63% growth. Amplia Therapeutics had revenue of 2.16M in the half year ending March 31, 2026, with 7.80% growth.

• Revenue: 4.79M
• Revenue Growth: +26.63%
• P/S Ratio: 12.32
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 59.03M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.79M	1.01M	26.63%
Mar 31, 2025	3.78M	-669.04K	-15.03%
Mar 31, 2024	4.45M	3.26M	274.34%
Mar 31, 2023	1.19M	-793.83K	-40.03%
Mar 31, 2022	1.98M	449.80K	29.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 20, 2026

Data Sources Report a data error